baber/WOPTO huggingface dataset:
Patent NZ-322517-A (NZ)
Title: Method for making palatinitol
Inventor: DUFLOT PIERRICK
IPC: C07H15/04
Filed: 1996-11-14
Abstract: A novel method for making palatinitol comprising a first step of epimerising isomaltose under conditions enabling a mixture of alpha-D-glucopyranosyl-(1->6)-D-mannose and isomaltose to be achieved, a second step of catalytically hydrogenating the mixture, and a third step of chromatographically depleting the isomaltitol in the hydrogenated mixture to give a roughly equimolecular mixture of alpha-D-glucopyranosyl-(1->6)-D-sorbitol and alpha-D-glucopyranosyl-(1->6)-D-mannitol.
Patent NZ-331330-A (NZ)
Title: a fine grain material providing a localised antimicrobial effect comprising an antimicrobial metal, alloy or compound thereof in a matrix with an inert biocompatible material
Inventor: BURRELL ROBERT EDWARD
IPC: A01N59/26
Filed: 1994-11-01
Abstract: A method of forming anti-microbial metal coatings, foils and powders which provide a sustained release of anti-microbial metal species when in contact with an alcohol or electrolyte.  The method comprises creating atomic disorder in the material under conditions which limit diffusion such that sufficient atomic disorder is retained in the material to provide release of atoms, ions, molecules or clusters of at least one of the metals so providing a localized anti-microbial effect.  Also claimed is a fine grain (less than 200nm) anti-microbial material comprising one or more anti-microbial metals selected from the group Ag, Au, Pt, Pd, Ir, Sn, Cu, Sb, Bi and Zn or alloys thereof, that is formed into a matrix with atoms or molecules of a different material selected from inert biocompatible metals (Ta, Ti, Nb, B, Hf, Zn, Mo, Si and Al), oxygen, nitrogen, hydrogen, boron, sulphur, oxides, nitrides, carbides, borides, sulphides and halides.
Patent NZ-336569-A (NZ)
Title: N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide and a phospholipid lung surfactant (recombinant SP-C derivative [two CYS residues replaced in position 4 and 5])
Inventor: GERMANN PAUL-GEORG
IPC: A61K45/06
Filed: 1998-02-14
Abstract: A synergistic composition for the treatment of IRDS and ARDS comprising N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide and/or its pharmacologically tolerable salts and lung surfactant comprising phospholipid.
Patent NZ-337609-A (NZ)
Title: Process for production of fluoroalochol by distillation in presence of base. Low evaporation residue fluoroalcohol and use in information recording media
IPC: C07C29/32
Filed: 1999-09-02
Abstract: This process for the production of a fluoroalcohol of the formula: H(CFRCF2)nCH2OH Where R is F or CF3 when n is 1 and R is F when n is 2, comprises reacting methanol with tetrafluoroethylene or hexafluoropropylene in the presence of a free radical source, and subjecting the reaction mixture to distillation in the presence of a base.
Patent NZ-504813-A (NZ)
Title: System and method of targeted marketing
Inventor: JONES III CHARLES L
IPC: G06Q10/06
Filed: 1998-10-26
Abstract: A system and method of targeted marketing to consumers, including businesses and associates (101, 103, 105, 107, 109, 111, 113) based upon the financial characteristics of the consumer, type offer being made and the channel of communication for delivery of the offer (119). The consumer is characterized based upon financial, behavioral, and socioeconomic factors. The offer is characterized based upon the consumer and the potential for the consumer accepting the offer. The channel of communication for delivery (119) of the offer is also characterized and combined with the consumer and consumer-offer characteristics to arrive at a net present value of the offer to be made. If the net present value is sufficient the offer is processed and presented to the consumer. If the net present value is not sufficient, the offer is revised to present a better value to the consumer (or discarded if the required offer value can not be created) thereby enhancing the chances that the consumer will accept the offer in question. In this way the system and method of the target marketing creates value in both releasing, and not releasing specific offers.
Patent NZ-505054-A (NZ)
Title: Capping seal system in form of threaded cap with seal between outer portion of neck and inner portion of cap
Inventor: HERD GUY NEIL
IPC: B65D41/00
Filed: 2000-06-09
Abstract: Disclosed is a container and cap assembly with a seal being provided by interaction of annular seal 6 of cup skirt 5 on a groove exterior to the container neck annulus.
Patent NZ-505762-A (NZ)
Title: Celecoxib composition with dosage between 10 mg and 1000 mg
Inventor: MAZHARY AHMAD M
IPC: A61K9/20
Filed: 1999-11-30
Abstract: Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising particulate celecoxib in an amount of about 10 mg to about 1000 mg in intimate mixture with one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
Patent NZ-509512-A (NZ)
Title: Moulded plastics tubular couplings with cylindrical inner or outer surface having flexible fin extending out of recess which engages and grips the surface of another component
Inventor: GUEST JOHN DEREK
IPC: F16L21/02
Filed: 2001-01-24
Abstract: The molded plastics tubular coupling has a cylindrical surface, an annular recess 19 with a flexible annular flange 20 formed in the recess and extending proud of the cylindrical surface so as to grip the corresponding surface of another component 16.
Patent NZ-510359-A (NZ)
Title: Amelioration of apomorphine adverse effects for sexual dysfunction in males and females
Inventor: EL-RASHIDY RAGAB
IPC: A61K31/473
Filed: 1999-07-01
Abstract: Adverse effects of apomorphine can be minimized by administering to a patient a threshold dose of apomorphine followed by administering a series of increasing periodic doses of apomorphine greater than the threshold dose until a final apomorphine dose in excess of a therapeutic dose has been received by the patient and then administering to the patient a therapeutic dose of apomorphine. The therapeutic dose of apomorphine to be administered is an amount sufficient to induce a penile erection sufficient for vaginal penetration in a male patient and an amount sufficient to ameliorate sexual dysfunction in a female patient by inducing clitoral erectogenesis and vaginal engorgement on stimulation of the female.
Patent NZ-510781-A (NZ)
Title: Treatment of vascular wilt diseases with an elicitor of Ophiostoma ulmi
Inventor: HUBBES MARTIN
IPC: A01N63/50
Filed: 1999-09-27
Abstract: A method of inducing resistance to a vascular wilt disease in susceptible plants by administering to said plants an elicitor obtainable from Ophiostoma ulmi. Also disclosed are nucleic acid molecules comprising nucleotide sequences encoding glycoprotein elicitors obtainable from Ophiostoma ulmi.
Patent NZ-514286-A (NZ)
Title: Production of a multilayered, textile floor covering using an aqueous polymeric dispersion as adhesive
Inventor: SMITH JAMES ARTHUR
IPC: D06N7/00
Filed: 2000-02-21
Abstract: A process for producing a textile floor covering having more than one layer, whereby the layers are bonded by an adhesive that has as a binder an aqueous dispersion of a mixture made from a polymer (A) that has at least 60% by weight of ethylene, a polymer (B) that has at least 60% by weight of dienes or dienes and vinylaromatics; whereby the proportion of (A) is from 0.5-50% and (B) is from 50-99.5% based on the total of (A) & (B).
Patent NZ-514595-A (NZ)
Title: Wide tracking range, auto ranging, low jitter phase lock loop for swept and fixed frequency systems
Inventor: KERNER THOMAS M
IPC: H03L7/087
Filed: 2001-10-03
Abstract: A wide tracking range phase locked loop (PLL) circuit is used to recover a clock signal with minimum jitter. The circuitry achieves this by using a programmable frequency discriminator (frequency search window), to avoid locking on to a harmonic of the desired signal, and a balance code detector, to minimise sensitivity to random data. The circuit guarantees signal acquisition without harmonic lockup.
Patent NZ-515557-A (NZ)
Title: Delivery system
Inventor: BRAITHWAITE PHILIP
IPC: A61M15/00
Filed: 2000-06-05
Abstract: There is described a medicament delivery device (1) which comprises a medicament reservoir (2), a medicament delivery passage (3) and a metering member (4) adapted to transfer a measured dose of medicament from the medicament reservoir to the delivery passage characterised in that the device is provided with a moisture proof barrier (9). The medicament delivery device is especially suited for use as an inhaler. There is therefore also described an inhaler which provides improved airflow for the dispersion of medicament, and a method of treating patients suffering from a respiratory disorder.
Patent NZ-521620-A (NZ)
Title: Sulfonamide derivatives their use as pharmaceuticals and preparation method thereof
Inventor: AIKINS JAMES ABRAHAM
IPC: A61P25/28
Filed: 2001-05-04
Abstract: A compound of formula (Ia) or a pharmaceutically acceptable salt thereof, which is useful for the treatment of conditions, associated with glutamate hypofunction, such as psychiatric and neurological disorders is disclosed.
Patent NZ-523122-A (NZ)
Title: Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
Inventor: AGARWAL PANKAJ
IPC: C12N1/19
Filed: 2000-06-22
Abstract: Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table I in diagnostic assays.
Patent NZ-526507-A (NZ)
Title: Methods and means for producing efficient silencing construct using recombinational cloning
Inventor: WESLEY SUSAN
IPC: C12N1/21
Filed: 2002-01-24
Abstract: A vector is described which comprises the following operably linked DNA fragments: (a) an origin of replication allowing replication in a recipient cell (1); (b) a selectable marker region (2) capable of being expressed in said recipient cell (1); and (c) a chimeric DNA construct comprising in sequence: (i) a promoter or promoter region (3) capable of being recognized by RNA polymerases of a eukaryotic cell; (ii) a first recombination site (4), a second recombination site (5), a third recombination site (6) and a fourth recombination site (7); (iii) a 3transcription terminating and polyadenylation region (8) functional in said eukaryotic cell; wherein said first recombination site (4) and said fourth recombination site (7) are capable of reacting with a same recombination site, and said second recombination site (5) and said third recombination site (6), are capable of reacting with a same recombination site; and wherein said first recombination site (4) and said second recombination site (5) do not recombine with each other or with a same recombination site or said third recombination site (6) and said fourth recombination site (7) do not recombine with each other or with a same recombination site. Described is a kit comprising the vector with at least one recombination protein capable of recombining a DNA segment. A method is disclosed for preparing a eukaryotic non-human organism, such as a plant, introducing chimeric DNA construct in the cells and isolating the eukaryotic non-human organism.
Patent NZ-528849-A (NZ)
Title: Container with longitudinal passageways for additional ventilation
Inventor: KOCH GREGORY FELIX
IPC: B65D5/20
Filed: 2002-03-15
Abstract: A ventilated container (22) includes a rectangular bottom panel (24) and first and second end panels (26, 28) connected to the bottom panel (24) which extend outwardly therefrom. There are first and second side panels (30, 32) connected to the bottom panel (24) which also extend outwardly therefrom. The side panels (30, 32) are connected to adjacent end panels (26, 28). Each of the panels has a longitudinal passageway (36, 38) extending therethrough to permit air to pass longitudinally through the panels (30, 32). In one embodiment of the invention each panel (26, 28, 30, 32) has at least two first apertures (60, 61, 62, 63, 64, 65, 67, 68, 69) extending therethrough, the first apertures being spaced-apart from the ends of each panel (26, 28, 30, 32). Preferably each panel (26, 28, 30, 32) has openings at the ends thereof, each communicating with one of the longitudinal passageways (36, 38). In one example the dimensions of the first and second panels (30, 32) compared to the third and fourth panels (26, 28) are in the proportion X:Y where X and Y are integers greater than 2. The number of first apertures (60, 61, 62, 63, 64, 65, 66, 67) are then the proportions (X-1):(Y-1). The passageways (36, 38) may be rectangular in section.
Patent NZ-529255-A (NZ)
Title: Agent for topical ophthalmic treatment of ocular inflammatory diseases
Inventor: UENO RYUJI
IPC: A61K31/445
Filed: 2002-04-12
Abstract: Disclosed is the use of a tricyclo compound as shown by formula (I) or its pharmaceutically acceptable salt for the manufacture of an agent for topical ophthalmic treatment of a human for ocular inflammatory diseases, wherein the substituents of formula (I) are as defined in the specification and the compound of formula (I) within the agent is in the concentration of 0.01%-0.1%
Patent NZ-529445-A (NZ)
Title: Orbital sander with fan blades arranged assymetrically to balance eccentrically mounted assembly
Inventor: PEOT DAVID G
IPC: B24B23/04
Filed: 2002-08-09
Abstract: Motor 22 drives a sanding platen 30 rotatable about an off-set axis. Fan blades are distributed angularly so as to balance the assembly.
Patent NZ-531500-A (NZ)
Title: Bed covering as cover partly detachable from part that has air permeability
Inventor: SPICER MICHEAL LLEWELLYN
IPC: A47G9/02
Filed: 2004-03-03
Abstract: A bed is disclosed having an air permeable part 13 with one or more cover sections 19, 20, at least a part of which is detachable so as to enable ventilation to occur through the air permeable part 13.
Patent NZ-538084-A (NZ)
Title: Clamping assembly
Inventor: VAN DE LOO PAUL
IPC: B25B5/06
Filed: 2003-08-08
Abstract: An adjustable clamp assembly is disclosed which includes an elongated cylindrical connection member, a gear assembly, and a first clamp. The elongated cylindrical connection member has a threaded portion proximate an end thereof and a longitudinal axis. The gear assembly includes a rotatable first gear member that has an axis of rotation substantially perpendicular to the longitudinal axis, and a second gear member cooperatively engaged with the first gear member. The first clamp member is connectable by screw-thread engagement with the threaded portion of the connection member wherein the elongated connection member, the gear assembly and the first clamp member are arranged such that rotation of the first gear member results in rotation of the cylindrical connection member and a linear motion of the first clamp member parallel to the longitudinal axis.
Patent NZ-541286-A (NZ)
Title: A fluid dispensing accessory
Inventor: BRAAMS JOHN
IPC: B05C17/005
Filed: 2004-02-10
Abstract: A nozzle for a caulking gun incorporates a resilient portion that is compressed when the trigger of the caulking gun is actuated and resumes its former shape when the trigger is released to expand the internal volume of the nozzle. The nozzle includes a resiliently compressible folded flange extending radially of the body portion adjacent to the inlet end of the nozzle.
Patent NZ-542530-A (NZ)
Title: System for culture and storage of benthic organisms in an aquatic environment
Inventor: MORTENSEN VIDAR
IPC: A01K61/59
Filed: 2004-02-27
Abstract: A system for culture and storage of benthic organisms in an aquatic environment includes at least two releasably interconnected stacked containers 35 for storing organisms, at least two lines 22a, 22b attached to the stack and connected to at least the upper portion of the stack, and a suspension device connected to the lines. The containers are interconnected so that individual containers can be removed by releasing the top container in the stack or a container in the middle of the stack for handling by an operator. The system may also include a working platform 32 and raising/lowering device(s) 31a, 31b for raising and lowering stacks.
Patent NZ-544877-A (NZ)
Title: Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
Inventor: KAUSCHKE STEFAN
IPC: A61P3/10
Filed: 2004-07-24
Abstract: Provided is the use of angiotensin II receptor antagonist selected from telmisartan and irbesartan or one of the salts thereof for preparing a pharmaceutical composition for treating people in whom type 2 diabetes mellitus has been diagnosed or who are suspected of prediabetes, for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal or elevated blood pressure. Further provided are similar uses with specific dosages and combinations with other drugs as well as methods of treating non-human animals with the composition.
Patent NZ-546068-A (NZ)
Title: Biocompatible, biostable coating of medical surfaces
Inventor: HORRES ROLAND
IPC: A61F2/82
Filed: 2004-09-29
Abstract: A medical product, wherein the product surface is coated at least partially with at least one biostable polysulfone layer and in that in, under and/or on the at least one biostable polysulfone layer at least one antiproliferative, anti-inflammatory, antiphlogistic and/or antithrombotic active agent is present.
Patent NZ-549438-A (NZ)
Title: Portfolio selection for (healthcare) technology investment
Inventor: FELDMAN JEFFREY L
Filed: 2005-01-26
Abstract: A computer-implemented method for creating an investment vehicle is disclosed. The method comprises selecting companies from a single sector of economic activity to form a subgroup, the subgroup having fewer companies than the sector, the selecting being based on involvement of each of the companies with development or marketing of at least one product associated with a product application that is predefined for the investment vehicle and that involves ongoing technological development. The method further comprises selecting companies from the subgroup for inclusion in the investment vehicle, the selecting from the subgroup may be based on criteria including at least one of: (a) a level of capitalization of each company, (b) a stage of economic development of the at least one product of each company, and (c) a financial condition of each company. The investment vehicle is formed from the companies selected from the subgroup and the investment vehicle is made available to a trading system. In one embodiment the investment vehicle is associated with a specific disease or diseases and the product application is at least one of (i) treatment of the specific disease or diseases, (ii) diagnosis of the specific disease or diseases, and (iii) treatment of symptoms of the specific disease or diseases.
Patent NZ-552666-A (NZ)
Title: Cationic Polymers Containing 2-Hydroxyethyl-methacrylate As Promoters For ASA Sizing
Inventor: PAWLOWSKA LUCYNA
IPC: C08F220/60
Filed: 2005-04-19
Abstract: The disclosure relates to cationic polymers or amphoteric polymers having a 2-hydroxyethyl methacrylate ranging from 1 to 30 mole percent, as defined in the specification, which are useful as papermaking additives for enhancing the sizing efficiency of a paper product. The disclosure also relates to methods for making and using such additives in making paper products.
Patent NZ-553286-A (NZ)
Title: Method and system for information selection and display in a communications network
Inventor: TAYLOR RICHARD CHARLES
IPC: H04L29/06
Filed: 2005-08-17
Abstract: A method of transmitting and displaying information on a client device in a communications network is provided. The information is transmitted to all client devices in the network and the client device is provided with means for comparing a characteristic of the information and predetermined parameters stored in the client device. The client device will only display information if the result of the comparison is positive.
Patent NZ-553602-A (NZ)
Title: Method for the production of diarylcycloakyl derivatives
Inventor: SALAGNAD CHRISTOPHE
IPC: C07C67/03
Filed: 2005-08-23
Abstract: Disclosed is a process for preparing compounds of formula (I), wherein the substituents are as defined in the specification, comprising the following steps: a1) reacting a compound of formula (IX) with water to give a compound of formula (V) in the presence of an enzyme which affords a suitable enantiomeric excess of compound (V), or a2) reacting a compound of formula (X) with at least one acyl donor to give compound (V) in the presence of an enzyme which affords a suitable enantiomeric excess of the compound (V), b) reacting the compound (V) in the presence of an acidic catalyst with a compound which can form the base-stable and acid-labile acetal or ketal protecting group Z3 to give a compound of formula (VIII) and c) converting the compound (VIII) in the presence of a nucleophile to a compound of formula (II), d) reacting the compound (II) in the presence of a base B1 with a compound of formula (VI) to give a compound of formula (lIla) or with a compound of the formula (VII) to give a compound of the formula (IIIb), e) converting the compound (IlIa) to a compound of formula (IVa) or the compound (IIIb) to a compound of formula (IVb), the particular reaction being effected with an alcohol in the presence of an acidic catalyst, f) reacting the compound (IVa) with the compound (VII) or the compound (IVb) with the compound (VI) to give a compound of formula (Ia) in the presence of the base B1 and g) if appropriate, hydrolyzing or hydrogenolyzing the compound (Ia) to give the compound (I) when R3 is H, the compounds (IX) and (X) each being present as the pure cis isomer or as cis/trans mixtures. Also disclosed are novel intermediates useful in the process.
Patent NZ-553712-A (NZ)
Title: Methods and apparatus for efficient VPN server interface, address allocation, and signaling with a local addressing domain
Inventor: O'NEILL ALAN
Filed: 2005-08-11
Abstract: A communications method for use in a communications system is disclosed. The system includes first and second addressing domains, a first set of addresses corresponding to the first addressing domain, a second set of addresses corresponding to the second addressing domain, a virtual private network and an upstream VPN interface identifier. The first addressing domain includes a first node the first node including a plurality of interfaces. The second addressing domain includes a second node. The virtual private network couples the first and second nodes. The upstream VPN interface identifier identifies an interface at the first node through which packets to be communicated over the VPN are forwarded to the second node. The method comprises operating the first node to receive from the second node address delegation information indicating at least one delegated address from the second set of addresses which the first node can assign; operating the first node, in response to receiving the address delegation information from the second node, to install a forwarding entry the forwarding entry associating a first node downstream interface with the first node upstream interface identified by the upstream VPN interface identifier; and operating the first node to receive a first packet including a source address having the value of the delegated address and information associating the source address with the second node. The first node selects as a function of the information associating the source address with the second node which one of a plurality of forwarding entries to use in determining an upstream VPN interface to be used to forward the received first packet.